AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2014

Sep 8, 2014

35134_dirs_2014-09-08_910286aa-708e-40dd-95ae-17c4cfcd85db.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-09-04

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-04	Common Stock	P	329	$5.3999	Acquired	654329	Direct
2014-09-04	Common Stock	P	226	$5.3998	Acquired	654555	Direct
2014-09-04	Common Stock	P	545	$5.4199	Acquired	655100	Indirect
2014-09-04	Common Stock	P	657	$5.4799	Acquired	655757	Indirect

Footnotes

F1: Owned by Elroy VI, LLC-owned 50% by Kelli Thompson (Mr. Thompsons's daughter) and 50% by Thompson Family Holdings, LLC (owned 100%
by Mr. Thompson).

F2: Owned by Elroy VII, LLC-owned 50% by Tommi Thompson (Mr. Thompsons' daughter) and 50% by Thompson Family Holdings, Inc. (owned 100% by Mr Thompson).